Now, superpill to revolutionise high BP treatment

A three-in-one superpill, launched in Britain on Tuesday, may revolutionize treatment for high blood pressure as it will cure millions suffering from the disease.

A three-in-one superpill, launched in Britain on Tuesday, may revolutionize treatment for high blood pressure as it will cure millions suffering from the disease.



The potent single treatment combines doses of three existing medications, cutting the number of tablets patients must take to manage their condition.

By offering three vital medicines in one, it is expected that the tablet will help increase the number of people getting the correct medication.



Almost two million people in the UK currently take three or more pills for hypertension – high blood pressure – but up to 80 per cent do not take their medication as directed, which increases their risk of suffering from a potentially fatal or disabling heart attack or stroke.

Made by Daiichi-Sankyo, the Prescription-only Sevicar HCT pills have been approved as a substitution therapy for patients whose blood pressure is already adequately controlled on combinations of three already available drugs.

“Many people with high blood pressure are required to take multiple pills every day to reduce their risk of stroke, but calculating when each needs to be taken can be confusing,” the Daily Mail quoted Dr Sharlin Ahmed, research liaison officer at The Stroke Association, as saying.

“Combining the pills into one could make taking the medication much simpler.”

“However, it’s important to note that this pill might not be suitable for everyone and it may have side effects so every patient should be assessed and treated on an individual basis,” Dr Ahmed added.

The first-of-its-kind superpill is available at a cost of just 26p.